Eli Lilly and Company (LLY) vs NVIDIA Corporation (NVDA)

See how Eli Lilly and Company and NVIDIA Corporation differ across market data and performance, so you can decide which asset best fits your strategy.

$1,156.73
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page
$220.78
NasdaqGS
NVIDIA is a leading designer of graphics processing units (GPUs). Historically, GPUs were used to improve performance and user experience across computing platforms, especially in PC gaming. Over time, GPUs have become essential semiconductors for artificial intelligence, powering large language models and other advanced AI workloads. In addition to AI-focused GPUs, NVIDIA provides its CUDA software platform, which supports AI model development and training. The company is also expanding its data center networking solutions, helping connect GPUs to manage increasingly complex workloads.
View Full Page

Key Metrics Comparison

Eli Lilly and CompanyLLY
Market Cap
$1.032T
Price
$1,156.73
24h Change
-1.52%
24h Volume
$3.03M
Employees
50,000
Shares Outstanding
944,818,881
NVIDIA CorporationNVDA
Market Cap
$5.331T
Price
$220.78
24h Change
+1.48%
24h Volume
$124.03M
Employees
42,000
Shares Outstanding
24,300,000,000

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
LLY
16.2%
NVDA
83.8%

Volume Share

Share of combined 24h volume

Volume Share
LLY
2.4%
NVDA
97.6%

24h Performance

Price change over last 24 hours

24h Performance
LLY
-1.52%
NVDA
1.48%
Price Comparison
Eli Lilly and Company
NVIDIA Corporation